International Conference​
& Galenus Workshop

Exploring the Future of Inhalation Drug Delivery

 

University of Parma, Italy

September 11-13, 2024

 

 

 

International Conference​
& Galenus Workshop

Exploring the Future of Inhalation Drug Delivery

 

University of Parma, Italy

September 11-13, 2024

 

 

 

AGENDA

SPEAKER TITLE                                         TIME
Francesca Buttini (University of Parma)

Cornelia Désirée Sonntag (Galenus Foundation)

Prof. Paolo Martelli (University Rector)

Prof. Gianni Galaverna (Head of Food and Drug Department)

Conference opening       9:00-9:25
 

NEW PARADIGMS IN LUNG DELIVERY

 

David Edwards (Harvard University, US) Chronic cough, airway rehydration, and climate change 9:25-9:55
Michael Hindle (Virginia Commonwealth University, US) Development of a lung surfactant powder aerosol product for babies with respiratory distress syndrome 9:55-10:20
Pavan Muttil (University of New Mexico, US) Formulation development and preclinical evaluation of aerosol vaccines: challenges, opportunities and lessons learnt 10:20-10:45

COFFEE BREAK + POSTER SESSION

Nicola Tsapis (Paris-Saclay University, France) Nanomedicines and microparticles for the treatment of pulmonary infections 11:25-11:50
David Cipolla (Insmed, US) Preclinical and CMC development of treprostinil palmitil inhalation powder 11:50-12:15
Paul Hagedoorn (University of Groningen, The Netherlands) The development of pulmonary levodopa applications for patients with Parkinson’s disease 12:15-12:40

LIGHT LUNCH + POSTER SESSION

 

RESPIRATORY TREE AS A SITE FOR THE DELIVERY OF BIOLOGICS

 

Tomaso Guidi (Chiesi, Italy) Inhaled biologics: current trends in the industry 14:20-14:40
Francesca Buttini (University of Parma, Italy) The formulation of protein and probiotics in dry powder inhalers 14:40-15:05
  To be selected from abstracts submitted 15:05-15:20
  To be selected from abstracts submitted 15:20-15:35

COFFEE BREAK + POSTER SESSION

Regina Scherließ (Kiel University, Germany) Nasal vaccine technology 16:15-16:40
Ben Forbes (King’s College, UK) Biologics from nose to brain 16:40-17:05
  To be selected from the abstract submitted 17:05-17:20

WELCOME RECEPTION

SPEAKER TITLE                                         TIME
 

BIOLOGICS LOVE LUNGS

 

Hugh Smyth (University of Texas at Austin, US) Developing inhaled mAbs and nucleic acids for therapeutic success 9:00-9:30
Jenny Lam (University of Central London, UK) How to make antibodies formulation stable and inhalable 9:30-9:55
  To be selected from abstracts submitted 9:55-10:10
  To be selected from abstracts submitted 10:10-10:25

COFFEE BREAK + POSTER SESSION

 

ENVIRONMENTAL PROTECTION BECOMES A REALITY IN THE DEVELOPMENT OF PMDI

 

Barzin Gavtash and Benjamin Myatt (Kindeva, UK) Atomization properties and aerosol characteristics of new low GWP propellants 11:05-11:30
Angelo Matturro (Chiesi, Italy) Transition to LGWP propellant using HFA152a 11:30-11:45
David Lechuga (Astra Zeneca, US) pMDI engineered particle suspensions in next generation propellants 11:45-12:10
Chris Baron (Aptar Pharma, France) Key learnings and pathways forward. Circumnavigating the challenges of your low GWP pMDI transition programs 12:10-12:25
Sergio Monti (RxPack Italy) Shifting tides: pMDI market scenarios into the low GWP propellant transition 12:25-12:40

LIGHT LUNCH + POSTER SESSION

 

LAST FRONTIERS IN LUNG INFECTION

 

Keertan Dheda (University of Cape Town, South Africa) Challenges in the prevention and management of drug-sensitive and drug-resistant Tuberculosis 14:20-14:45
Lea Ann Dailey (University of Vienna, Austria) A liposomal strategy for inhaled bedaquiline: in vivo pharmacodynamics and pharmacokinetics 14:45-15:10
Francesca Ungaro (University of Naples, Italy) Novel formulation approaches for lung infection treatment 15:10-15:35
Mirjam Kobler (H&T Presspart, UK) The sunriser – achieving high performance in challenging formulations 15:35-15:50

COFFEE BREAK + POSTER SESSION

PhD Students Contest Seven7th Seven talks of 7 minutes selected from abstract submission 16:20-17:20

GALA DINNER

SPEAKER TITLE TIME
 

NEW RESEARCH

 

Federico Lavorini (University of Florence, Italy) Physiological and technological barriers in the treatment of COPD 9:00-9:30
Jan de Backer (FLUIDDA, USA) The role of digital twins and in-silico trials as regulatory tools for the authorization of orally inhaled drugs 9:30-9:55
Carsten Ehrhardt (Trinity College, Ireland) Uptake mechanisms of molecules released into the lungs 9:55-10:20

COFFEE BREAK + POSTER SESSION

Daniela Traini (Macquarie University, Australia) Non-clinical tests in the evaluation of inhaled pharmaceuticals 11:00-11:25
Per Bäckmann (Emmace, Sweden) Physiologically-based biopharmaceutical models- a tool to understand local and systemic exposure of inhaled medicines 11:25-11:50
Amrit Paude (Amrit Paude) Empowering drug-drug co-amorphous inhaled formulation design using data-driven approach 11:50-12:15
Noémi Stefánia Csaba (University of Santiago de Compostela, Spain) A multi-stage pulmonary drug delivery system based on sporopollenin 12:15-12:40

CLOSING REMARKS

AGENDA

Francesca Buttini (University of Parma), Cornelia Désirée Sonntag (Galenus Foundation), Prof. Paolo Martelli (University Rector), Prof. Gianni Galaverna (Head of Food and Drug Department)
Conference Opening     
9:00-9:25

 

NEW PARADIGMS IN LUNG DELIVERY

David Edwards (Harvard University, US)
Title TBA
9:25-9:55  

 

Michael Hindle (Virginia Commonwealth University, US)
Development of a Lung Surfactant Powder Aerosol Product for Babies with Respiratory Distress Syndrome
9:55-10:20  

 

Pavan Muttil (University of New Mexico, US)
Formulation Development and Preclinical Evaluation of Aerosol Vaccines: Challenges, Opportunities and Lessons Learnt
10:20-10:45

 

COFFEE BREAK + POSTER SESSION  

 

Nicola Tsapis (Paris-Saclay University, France)
Nanomedicines and microparticles for the treatment of pulmonary infections
11:25-11:50  

 

David Cipolla (Insmed, US)
Preclinical and CMC Development of Treprostinil Palmitil Inhalation Powder (IPF)
11:50-12:15  

 

Paul Hagedoorn (University of Groningen, The Netherlands)
The development of pulmonary levodopa applications for patients with Parkinson’s disease
12:15-12:40

 

LIGHT LUNCH + POSTER SESSION  

 

RESPIRATORY TREE AS A SITE FOR THE DELIVERY OF BIOLOGICS

Tomaso Guidi (Chiesi, Italy)
Inhaled Biologics: current trends in the industry
14:20-14:40  

 

Francesca Buttini (University of Parma, Italy)
The formulation of protein and probiotics in dry powder inhalers
14:40-15:05  

 

To be selected from abstracts submitted
15:05-15:20  

 

To be selected from abstracts submitted
15:20-15:35

 

COFFEE BREAK + POSTER SESSION 

 

Regina Scherließ (Kiel University, Germany)
Nasal vaccine technology
16:15-16:40  

 

Ben Forbes (King’s College, UK)
Biologics from nose to brain
16:40-17:05  

 

To be selected from the abstract submitted
17:05-17:20

 

WELCOME RECEPTION

 

BIOLOGICS LOVE LUNGS

Hugh Smyth (University of Texas at Austin, US)
Developing inhaled mAbs and nucleic acids for therapeutic success
9:00-9:30

 

Jenny Lam (UCL, UK)
How to make antibodies formulation stable and inhalable
9:30-9:55

 

To be selected from abstracts submitted
9:55-10:10

 

To be selected from abstracts submitted
10:10-10:25

 

COFFEE BREAK + POSTER SESSION  

 

ENVIRONMENTAL PROTECTION BECOMES A REALITY IN THE DEVELOPMENT OF PMDI

Barzin Gavtash (Kindeva, UK)
Atomization properties and aerosol characteristics of new low GWP propellants
11:05-11:30  

 

Angelo Matturro (Chiesi, Italy)
Transition to LGWP propellant using HFA152a
11:30-11:45

 

David Lechuga (Astra Zeneca, US)
pMDI engineered particle suspensions in next generation propellants
11:45-12:10  

 

Chris Baron (Aptar Pharma, France)
Key learnings and pathways forward. Circumnavigating the challenges of your low GWP pMDI transition programs
12:10-12:45

 

Sergio Monti (RxPack Italy) Shifting tides: pMDI market scenarios into the low GWP propellant transition
12:25-12:40

 

LIGHT LUNCH + POSTER SESSION  

 

 

LAST FRONTIERS IN LUNG INFECTION

Keertan Dheda (University of Cape Town, South Africa)
Challenges in the prevention and management of drug-sensitive and drug-resistant Tuberculosis
14:20-14:45

 

Lea Ann Dailey (University of Vienna, Austria)
A liposomal strategy for inhaled bedaquiline: in vivo pharmacodynamics and pharmacokinetics
14:45-15:10

 

Francesca Ungaro (University of Naples, Italy)
Novel formulation approaches for lung infection treatment
15:10-15:35

 

Mirjam Kobler (H&T Presspart, UK)
The Sunriser – achieving high performance in challenging formulations
15:35-15:50

 

GALA DINNER

 

NEW RESEARCH

Federico Lavorini (University of Florence, Italy)
Physiological and Technological barriers in the treatment of COPD
9:00-9:30

 

Jan de Backer (FLUIDDA, USA)
The role of digital twins and in-silico trials as regulatory tools for the authorization of orally inhaled drugs
9:30-9:55

 

Carsten Ehrhardt (Trinity College, Ireland)
Uptake mechanisms of molecules released into the lungs
9:55-10:20

 

COFFEE BREAK + POSTER SESSION  

 

Daniela Traini (Macquarie University, Australia)
Non-Clinical Tests in the Evaluation of Inhaled Pharmaceuticals
11:00-11:25

 

Per Backmann (Emmace, Sweden)
Physiologically-based biopharmaceutical models- a tool to understand local and systemic exposure of inhaled medicines
11:25-11:50

 

Amrit Paudel (RCPE, Austria)
Empowering drug-drug co-amorphous inhaled formulation design using datadriven approach
11:50-12:15

 

Noémi Stefánia Csaba (University of Santiago de Compostela, Spain)
A multi-stage pulmonary drug delivery system based on sporopollenin
12:15-12:40

CLOSING REMARKS

 

CONFIRMED SPEAKERS